Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ARGS

Argos Therapeutics

$0.19

0.01 (5.71%)

09:55
09/20/17
09/20
09:55
09/20/17
09:55
Conference/Events
Argos Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ARGS

Argos Therapeutics

$0.18

0.0012 (0.69%)

08:54
09/19/17
09/19
08:54
09/19/17
08:54
Conference/Events
Argos Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

Over a month ago
ARGS

Argos Therapeutics

$0.20

-0.008 (-3.85%)

08:16
09/12/17
09/12
08:16
09/12/17
08:16
Hot Stocks
Argos Therapeutics reports on interim analysis of Phase 3 ADAPT Trial »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$0.20

0.0043 (2.15%)

08:13
09/06/17
09/06
08:13
09/06/17
08:13
Hot Stocks
Argos Therapeutics doses first HIV patient with AGS-004 »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$0.19

-0.0105 (-5.30%)

08:31
08/21/17
08/21
08:31
08/21/17
08:31
Hot Stocks
Argos Therapeutics to present interim analysis from Phase 3 ADAPT trial at ESMO »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$0.22

-0.005 (-2.27%)

16:21
08/16/17
08/16
16:21
08/16/17
16:21
Syndicate
Breaking Syndicate news story on Argos Therapeutics »

Argos Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$0.26

0.0127 (5.18%)

17:06
08/09/17
08/09
17:06
08/09/17
17:06
Earnings
Argos Therapeutics reports Q2 EPS (21c), consensus (26c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ARGS

Argos Therapeutics

$0.39

-0.0155 (-3.80%)

08:49
06/16/17
06/16
08:49
06/16/17
08:49
Syndicate
Argos Therapeutics announces $6M secured convertible note financing »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$0.41

0.0027 (0.66%)

08:23
05/10/17
05/10
08:23
05/10/17
08:23
Hot Stocks
Argos Therapeutics provides ADAPT trial update after FDA meeting »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$0.39

-0.023 (-5.55%)

16:12
04/18/17
04/18
16:12
04/18/17
16:12
Hot Stocks
Argos reports interim results of ADAPT Trial »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.